Pharmacology & Toxicology · 1991 · 26 citations · 18 references
MedicinePharmacokineticsPharmacologyBioavailabilityBone MetabolismClinical PharmacologyDrug DispositionDrug DistributionDrug Half-lifeDrug Distribution To BoneIntramuscular Medication AdministrationPharmacokinetic ParametersPharmacokinetics Of Intravenous DrugsPharmacokinetics Of Subcutaneous AdministrationSubcutaneous Drug AdministrationSubcutaneous Medication Administration
The pharmacokinetics of clodronate was studied in rats after single intravenous, intramuscular and subcutaneous doses of a mixture of unlabelled and 14C-labelled disodium clodronate (25 mg/5 muCi/kg). The peak clodronate concentration in plasma was reached within 5 min., and the drug was eliminated with a half-life of about 1.5 hr regardless of administration route. Bioavailabilities after intramuscular and subcutaneous administration were 105% and 89%, respectively. During the 72 hr collection period, the mean share of clodronate recovered from the urine was about 53% of the dose regardless of administration route. Most of the drug was excreted during the first 24 hr. The amount of clodronate in bone (femur) was 186 micrograms/g tissue at 2 hr after intravenous administration, 188 micrograms/g after intramuscular administration and 157 micrograms/g after subcutaneous administration. It is concluded that absorption of clodronate after intramuscular and subcutaneous administration is rapid and good, and that the concentrations of the drug in bone after 2 hr are about the same as after intravenous administration.
18
Goodman and Gilman's The Pharmacological Basis of Therapeutics
Annals of Internal Medicine · 1991 · 1.2K citations
Clodronate kinetics and bioavailability
Gerald J. Yakatan, Wesley J. Poynor, Robert L. Talbert et al. · Clinical Pharmacology & Therapeutics · 1982 · 119 citations